Identification of the non-proteolytic mechanism of NLRP1 activation

NLRP1 激活的非蛋白水解机制的鉴定

基本信息

  • 批准号:
    9234453
  • 负责人:
  • 金额:
    $ 10.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Inflammasomes are innate immune sensing pathways designed to identify and clear infectious agents through production of pro-inflammatory mediators and pyroptotic cell death. Selective targeting of inflammasomes and their sensors, the NLRPs, is emerging as an important means of modulating the immune response in vaccinology, tumor therapy and treatment of autoimmunity. However, only two molecular mechanisms of NLRP activation have been described to date: NLRP1 proteolysis by Bacillus anthracis lethal factor and flagellin binding by the NAIPs/NLRC4 inflammasome. I have recently determined that NLRP1 also drives a host-protective inflammasome response to the protozoan parasite Toxoplasma gondii. In contrast to the previously described mechanism of NLRP1 activation by anthrax, however, NLRP1 is not proteolytically processed in response to Toxoplasma infection, leading to the hypothesis that NLRP1 has evolved to detect parasite infection via a novel, undescribed mechanism. This K22 award will provide the experimental resources, time and training to identify the critical components of the NLRP1 sensing pathway. Specifically, this award will allow me to develop 1) skills in the design and implementation of forward genetic screens, 2) tools and expertise in reverse genetic engineering of parasites, 3) biochemical tools to probe the essential components of NLRP1 for sensor activation. These studies address an understudied area in immunology: how eukaryotic pathogens are sensed by the innate immune system. Moreover, by exploiting the natural allelic variation in NLRP1 in parallel with a parasite genetics approach I will establish a unique set of tools to define the molecular underpinnings of NLRP1 activation that will be broadly important to our understanding of inflammasome biology. Specifically, the central goals of this project are to 1) identify the parasite components that trigger NLRP1 activation and 2) determine the critical residues in NLRP1 that mediate this response.
 描述(由申请人提供):炎性小体是先天性免疫传感途径,旨在通过产生促炎介质和致炎细胞死亡来识别和清除感染因子。选择性靶向炎性小体及其传感器,NLRP,正在成为疫苗学,肿瘤治疗和自身免疫治疗中调节免疫应答的重要手段。然而,迄今为止仅描述了两种NLRP激活的分子机制:炭疽杆菌致死因子引起的NLRP 1蛋白水解和NAIP/NLRC 4炎性体引起的鞭毛蛋白结合。我最近确定NLRP 1也驱动宿主对原生动物寄生虫弓形虫(Toxoplasma gondii)的保护性炎症反应。然而,与先前描述的炭疽激活NLRP 1的机制相反,NLRP 1在弓形虫感染时不被蛋白水解处理,这导致了NLRP 1已经进化为通过一种新的、未描述的机制来检测寄生虫感染的假设。该K22奖项将提供实验资源,时间和培训,以确定NLRP 1传感途径的关键组成部分。 具体来说,该奖项将使我能够发展1)正向遗传筛选的设计和实施技能,2)寄生虫反向遗传工程的工具和专业知识,3)探测NLRP 1传感器激活的基本组成部分的生化工具。这些研究解决了免疫学中一个未充分研究的领域:先天免疫系统如何感知真核病原体。此外,通过利用NLRP 1中的天然等位基因变异与寄生虫遗传学方法并行,我将建立一套独特的工具来定义NLRP 1激活的分子基础,这对我们理解炎性小体生物学非常重要。具体而言,该项目的中心目标是:1)确定触发NLRP 1激活的寄生虫组分; 2)确定NLRP 1中介导这种反应的关键残基。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.
  • DOI:
    10.3389/fimmu.2017.00301
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Tosello-Trampont A;Surette FA;Ewald SE;Hahn YS
  • 通讯作者:
    Hahn YS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah E. Ewald其他文献

Myeloid-mediated IL-1R signaling in immuno-responsive Thy-1 negative fibroblasts is critical for pulmonary fibrosis
免疫反应性 Thy-1 阴性成纤维细胞中骨髓介导的 IL-1R 信号传导对于肺纤维化至关重要
  • DOI:
    10.1101/2021.05.11.443647
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Abebayehu;Chiuan;G. C. Bingham;Sarah E. Ewald;T. Barker
  • 通讯作者:
    T. Barker
Automated Spatially Targeted Optical Micro Proteomics (AutoSTOMP) 2.0 identifies proteins enriched within inflammatory lesions in tissue sections and human clinical biopsies
自动空间靶向光学微蛋白质组学 (AutoSTOMP) 2.0 可识别组织切片和人体临床活检中炎症病变中富集的蛋白质
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bocheng Yin;Laura R Caggiano;Rung‐chi Li;E. McGowan;Jeffery W Holmes;Sarah E. Ewald
  • 通讯作者:
    Sarah E. Ewald
Title 051310
标题 051310
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sarah E. Ewald
  • 通讯作者:
    Sarah E. Ewald
How colonization bottlenecks, tissue niches, and transmission strategies shape protozoan infections
殖民化瓶颈、组织生态位和传播策略如何塑造原生动物感染
  • DOI:
    10.1016/j.pt.2023.09.017
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    6.600
  • 作者:
    Dana A. May;Fatima Taha;Matthew A. Child;Sarah E. Ewald
  • 通讯作者:
    Sarah E. Ewald
The Myeloid Receptor PILRβ Mediates the Balance of Inflammatory Responses through Regulation of IL-27 Production
骨髓受体 PILRβ 通过调节 IL-27 的产生介导炎症反应的平衡
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    C. Tato;B. Joyce;A. Banerjee;Yi Chen;M. Sathe;Sarah E. Ewald;Man;D. Gorman;T. Mcclanahan;J. Phillips;P. Heyworth;D. Cua
  • 通讯作者:
    D. Cua

Sarah E. Ewald的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah E. Ewald', 18)}}的其他基金

Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
通过损伤相关分子途径 (DAMP) 分子附着提高生物材料植入物的耐受性
  • 批准号:
    10399599
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Innate Inflammatory Control of Cachexia
恶病质的先天炎症控制
  • 批准号:
    10210275
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Innate Inflammatory Control of Cachexia
恶病质的先天炎症控制
  • 批准号:
    10028888
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Proteomic interrogation of the parasite vacuole using autoSTOMP
使用 autoSTOMP 对寄生虫液泡进行蛋白质组学研究
  • 批准号:
    10307153
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
通过损伤相关分子途径 (DAMP) 分子附着提高生物材料植入物的耐受性
  • 批准号:
    10210393
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Innate Inflammatory Control of Cachexia
恶病质的先天炎症控制
  • 批准号:
    10404638
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Innate Inflammatory Control of Cachexia
恶病质的先天炎症控制
  • 批准号:
    10818772
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
通过损伤相关分子途径 (DAMP) 分子附着提高生物材料植入物的耐受性
  • 批准号:
    10057727
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:
Innate Inflammatory Control of Cachexia
恶病质的先天炎症控制
  • 批准号:
    10624280
  • 财政年份:
    2020
  • 资助金额:
    $ 10.7万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 10.7万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 10.7万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 10.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了